JanOne Inc. (JAN) is a unique company focused on reducing opioid addiction and exploring possibilities in the arena of non-addictive pain medications. It was previously known as Appliance Recycling Centers of America, but rebranded and shifted its focus towards biotechnology and drug development in its fight against the opioid crisis. This transformative business strategy was designed to address one of the most critical healthcare issues facing our society today.
Headquartered in Las Vegas, Nevada, JanOne's change of direction signifies its commitment to alleviate the suffering that results from opioid addiction and chronic pain. The company is committed to finding and developing drugs that will combat pain without the addictive effects that are commonly associated with opiate-based medicine.
Taking a multi-faceted approach, JanOne also engages in recycling in a bid to reduce its carbon footprint and contribute to environmental sustainability. This approach consists of recycling appliances such as refrigerators and freezers, in compliance with the U.S. Environmental Protection Agency standards.
JanOne's commitment to addressing the opioid crisis is epitomized in its acquisition of drug candidate TV-45070 from Teva Pharmaceuticals. TV-45070, a non-opiate drug, has shown promising results in Phase 2 clinical studies for treating Neuropathic Pain. JanOne aims to bring this drug to market, trusting that it will serve as a more effective and less addictive pain medication.
In addition to its initiatives in non-addictive pain management, JanOne Inc. maintains a subsidiary, ARCA Recycling. This arm of the company focuses on providing comprehensive turn-key recycling services for utilities and other appliance retailers, effectively helping them to recycle their old appliances responsibly.
Thus, JanOne Inc. is more than just a biotech firm. It embodies a commitment to societal well-being on multiple fronts - from its aggressive approach to combatting the opioid crisis through innovative, non-addictive pain solutions, to its blueprints for eco-friendly appliance recycling. As the company advances its drug development and recycling initiatives, it continues manifesting its dedication to both healthcare and environmental sustainability. JanOne is unambiguous in its mission to bring about a change, transforming lives via its biotech segment and conserving the environment through its recycling operations.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Janus Living, Inc. announced the completion of its $18.4 million public offering of Class A-1 common stock, including the full exercise of the underwriters' overallotment option for an additional 2.4 million shares. The offering was made under a registration statement on Form S-11, with the underwriting agreement executed with BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities. The company also confirmed its status as an emerging growth company.
Janus Living, Inc. (NYSE:JAN) has announced a public offering of 16 million shares of its Class A-1 common stock, with underwriters having an option to purchase an additional 2.4 million shares. The senior housing REIT intends to use the proceeds for acquisitions, investment opportunities, and general corporate purposes. BofA Securities, J.P. Morgan, and Wells Fargo Securities are managing the offering, which is pending SEC approval.
Janus Living has priced a public offering of 16 million shares of Class A-1 common stock at $29 per share, with underwriters having an option to purchase an additional 2.4 million shares. The offering is expected to close on August 12, 2026, and the proceeds will be used for acquisitions, investments, and general corporate purposes. BofA Securities, J.P. Morgan, and Wells Fargo Securities are leading the offering.